Natural compounds in Animal Health MediWales Karolina Bate

Similar documents
PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Workshop on Strengthening livestock health and Veterinary Services. Kiev, 2-3 November 2010 TAIEX, AGR 42266

Further memorandum submitted by the Department for Environment, Food and Rural Affairs

Session 1: An introduction to the new requirements under the Food and Drug Regulations affecting industry and health care practitioners who compound

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Proposal for a Regulation on veterinary medicinal products

Irish Medicines Board

Irish Medicines Board

UNAPPROVED VETERINARY DRUGS

Personal Protection: Topical Repellents

They're not all the same: Why FDA approval of animal drugs matters

Center for Veterinary

ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION

Irish Medicines Board

MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Legislation on Veterinary Medicinal Products (VMPs) and legal status of relevant VMPs for anesthesia of finfish

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP FOUGERES cedex FRANCE

No July 2000 REGULATION. respecting veterinarians authorisations to prescribe drugs SECTION II

Medicines for bees. Establishment of maximum residue limits. Principles for marketing authorisations

Guideline on quality data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market

Company: Richter Pharma AG MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

FDA S ANTIPARASITIC RESISTANCE MANAGEMENT STRATEGY (ARMS)

BSc, PhD, MBA, LLM, MSc (Med Sci), DAgVetPharm, FRPharmS, FCPP, FIPharmM, MPS (NZ), FNZCP, FFHom

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

EU Statistical Data of all uses of animals

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

Snapshot Current Vet Drugs AMR Initiatives

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION

Opinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004

American Veterinary Medical Association

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018

F. MUTINELLI. European Agency for the Evaluation of Medicinal Products (EMEA)

GENERAL CONDITIONS FOR THE MARKETING AUTHORISATION

Regulating Animal Welfare in the EU.the EU.

CFA Veterinary Residues Management Guidance

EU Statistical Data of all uses of animals

January 23, 2014 Anna O Brien, DVM Veterinary Medical Officer Office of New Animal Drug Evaluation Center for Veterinary Medicine-FDA

EU Statistical Data of all uses of animals

Import control of meat

Reflection paper on promotion of pharmacovigilance reporting

State system for animal identification and registration in Ukraine

DP.1. Control tables

DP.1. Control tables

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Private Sector Perspectives IFAH (worldwide)

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

COMMISSION NOTICE Guidelines for the prudent use of antimicrobials in veterinary medicine (2015/C 299/04) Table of Contents

Maximum Residue Limits (MRLs) and Consumer safety. Presented by: Isaura Duarte, European Medicines Agency

1. ABOUT THE CONSULTATION

Scientific discussion

VETERINARY MEDICINAL PRODUCTS CONTROLLING VARROA JACOBSONI AND ACARAPIS WOODI PARASITOSIS IN BEES

The OIE Relevant Standards and Guidelines for Vaccines

Review of Legislation for Veterinary Medicinal Products Version 2

PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

The OIE Relevant Standards and Guidelines for Veterinary Medicinal Products

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

Summary of Product Characteristics

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE

Medicines for Bees An introduction to the subject and aim of the workshop Role of the Agency in the initiative

PARAMYXOVIRUS - MAKING SURE YOU USE ONLY AUTHORISED MEDICINES: ADVICE FROM THE VETERINARY MEDICINES DIRECTORATE (VMD)

CHALLENGES FACED BY AH SECTOR AN INDIAN PERSPECTIVE

LABELLING AND PACKAGE LEAFLET

INFORMATION NOTE ON ANTIBIOTIC RESISTANCE AND THE RESPONSIBLE USE OF ANTIBIOTICS IN FARM ANIMALS

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Small Animal Segment Underestimated Yet Essential

EPAR type II variation for Metacam

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

THE SAFE STRIP. *No residues in honey beyond the maximum limits. when used according to label instructions.

Public Assessment Report Scientific discussion

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

The Regulation of medical devices in the European Union

European Public MRL assessment report (EPMAR)

Veterinary medicines. Prescriptions 2. Dispensing veterinary medicines 3. Storage of poisons and restricted substances 5

DIRECTIVE 2001/82/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to veterinary medicinal products

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Product Performance Test Guidelines OPPTS Treatments to Control Pests of Humans and Pets

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

Council of the European Union Brussels, 17 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

Regulatory Framework for the Availability and Use of Animal Drugs in the United States

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

GUIDANCE FOR VETERINARY SURGEONS. Use of norethisterone for oestrus suppression in racing bitches in Great Britain

FREEDOM OF INFORMATION (FOI) SUMMARY

Good clinical practice a tool to refine fish research - an assessors view

Veterinary Medicines Directorate

Ministry for Primary Industries Manato Ahu Matua

STATE OF CONNECTICUT

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Metacam 1.5 mg/ml oral suspension for dogs

PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 12 to 14 October 2004

Request for advice on the impact on public health and animal health of the use of antibiotics in animals

Transcription:

Natural compounds in Animal Health 27.04.2016 MediWales Karolina Bate 1

Natural compounds in Animal Health Nature creates ability; luck provides it with opportunity- Francois De La Rouchefoucauld 1. Overview of where natural compounds are found in Animal Health 2. Veterinary medicines: When do you need a Marketing Authorisation? What data is required? Examples of natural compounds in veterinary medicines Case study - new veterinary medicine - use the cascade to your advantage 3. Unregulated veterinary products: Potential for certain animal products to be less regulated Animal skincare products 4. Summary 2

Natural compounds found in all Animal Health areas An important role Biocides Veterinary Medicines Insecticides Cosmetics Natural Compounds Herbals Shampoos Nutraceuticals Feed materials Feed Additives 3

When do you need a Marketing Authorisation? Natural compounds in Veterinary Medicinal Products A Marketing Authorisation is required if: medicinal claims are made the product contains certain ingredients that exert a pharmacological effect Herbals and Nutraceuticals require authorisation if medicinal claims are made UK enforcement agency is kept very busy Exemption for small pet animals Aquarium fish, cage birds, homing pigeons, small rodents, ferrets and rabbits Oral or topical, manufactured to GMP Active ingredient must be on approved list 4

Data required for authorisation of veterinary medicines In comparison with human medicines Administrative Vet PV requirements less stringent No PIL user-testing for vet package leaflet CMC Almost identical Efficacy Overlap with pre-clinical data requirements Differences in clinical requirements Safety Vet safety has multiple aspects User, consumer (food producing species, MRL) and environment (food producing species, ERA) MRL and ERA for natural compounds MRL data package could be significantly reduced ERA would stop in Phase I without the need for any testing or calculations Depending on compound 5

Thymol: Example of successful natural compound in veterinary medicine Treatment of varroosis due to Varroa destructor in honeybees Aids in the reduction of inflammation and alleviates pain in horses 6

Battle against anti-microbial resistance Natural extract from pineapple stem Medical and veterinary communities share concerns over the development of microbial resistance Anti-microbial use in animals is being highly monitored Policies must focus on Responsible Use Vet pharma companies are unlikely to invest in new anti-microbials in the near future New alternative to antibiotic (to be authorised in 2017) Non-antibiotic, anti-infective for use in diarrhoea in pigs Recently awarded US sponsor fee waiver 7

Natural compounds under the cascade Case study company strategy Equine health has a historical high off label use of human medicinal products An opportunity to be the first to authorise a Veterinary Medicinal Product Initial complete market share 8

Potential for natural compounds to be less regulated Not without complications Product type Human Vet Medicinal ü ü Homeopathic ü ü Herbal ü û Cosmetic ü û Medical device ü û Medicinal herbal falls under vet medicine scope (Dir. 2001/82) Less regulated area 9

Animal skincare products, no specific EU regulations Often include natural compounds Skincare products, used by 127 million dogs & cats Annual turnover 70 million 15% growth during the last 24 months Shampoos, sprays, lotions, wipes, soaps, foams These products make no medicinal claims (revitalise coat, add shine, soften dry skin, control perspiration ) Not under the scope of veterinary medicines directive (2001/82/EC) There is no veterinary cosmetics regulation The complication is regulatory uncertainty: Individual EU Member States can interpret legislation differently 10

Natural compounds in Animal Health Summary Natural compounds are found across all aspects of Animal Health For regulated medicinal products, there is the potential for a reduced data set for natural compounds There are significant opportunities to market natural compounds in unregulated areas 11

Thank you for listening 12